⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

May 1, 1992Current Opinion on Therapeutic Patents

Overview: PAF Receptor Antagonists: Recent Advances

View at Publisher

Ask AI

Bookmark

Share

Abstract

(1992). Overview: PAF Receptor Antagonists: Recent Advances. Current Opinion on Therapeutic Patents: Vol. 2, No. 5, pp. 583-623.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Mark Whittaker (1992) studied this question.

synapsesocial.com/papers/6a94f07d77bd7906860f2d43 https://doi.org/10.1517/13543776.2.5.583

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Natural antagonists of platelet‐activating factorIn Vitro Study · 1988 · 30 citations
2Molecular cloning and expression of platelet-activating factor receptor from human leukocytes.Original Research · 1991 · 296 citations
3Specific receptor sites for 1-0-alkyl-2-0-acetyl-sn-glycero-3-phosphocholine (platelet activating factor) on rabbit platelet and guinea pig smooth muscle membranesOriginal Research · 1983 · 223 citations
44-Substituted 2-alkoxytetrahydrofurans as potent and long-lasting PAF antagonistsIn Vitro Study · 1992 · 12 citations
5Effects of PAF‐antagonists in mouse ear oedema induced by several inflammatory agentsIn Vitro Study · 1991 · 42 citations

More related papers

Chemical synthesis and physiological activity of sulfonium analogues of platelet activating factor1991
Hexadecylphosphocholine: Preclinical and the first clinical results of a new antitumor drug1991
Pentadienyl carboxamide derivatives as antagonists of platelet activating factor1989

More from Current Opinion on Therapeutic Patents

Overview: Oncologic, Endocrine & Metabolic Antisense oligonucleotides for the treatment of cancerWed,
Overview:In VivoExpression of Human GenesFri,